Inositol and human reproduction. From cellular metabolism to clinical use
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Inositol is an organic compound of high biological importance that is widely distributed in nature. It belongs to the sugar family and is mainly represented by its two dominant stereoisomers: myo-inositol and D-chiro-inositol that are found in the organism in the physiological serum ratio 40:1. Inositol and its derivatives are important components of the structural phospholipids of the cell membranes and are precursors of the second messengers of many metabolic pathways. A high concentration of myoinositol is found in the follicular fluid and in semen. Inositol deficiency and the impairment of the inositol-dependent pathways may play an important role in the pathogenesis of insulin resistance and hypothyroidism. The results of the research also point out the potential beneficial role of inositol supplementation in polycystic ovarian syndrome and in the context of assisted reproduction technologies and in vitro fertilization. The main aim of the article is to overview the major inositol-dependent metabolic pathways and to discuss its importance for reproduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MI is also involved in reproductive functions, including follicle stimulating hormone (FSH)-mediated pathways, which regulate the proliferation and maturation of granulosa cells (9).”
Citations
Cites
3 retracted
Papaleo, E., Unfer, V., Baillargeon, J.-P., Fusi, F., Occhi, F., & De Santis, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.01.088 · Cited by 197
Retracted- Retracted
RETRACTED: Contribution of myo-inositol to reproduction
Papaleo, E., Unfer, V., Baillargeon, J., & Chiu, T. T. Y. (2009) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2009.09.008 · Cited by 88
RetractedPhosphoinositides in cell regulation and membrane dynamics
Di Paolo, G., & De Camilli, P. (2006) · Nature · doi:10.1038/nature05185 · Cited by 2,790 · cited 1×
“Cell membrane phospholipids are the source of inositol triphosphate (IP3), diacylglycerol (DAG) and inositolphosphoglycans (IPG) that act as second messengers of many metabolic pathways, including those depending on thyroid stimulating hormone (TSH), follicular stimulating hormone (FSH), luteinizing hormone (LH) and i…”
BackgroundMen at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302 · cited 1×
“up to 80% of patients with PCOS), especially in overweight/obese patients [40].”
BackgroundWild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2724 · Cited by 1,010
NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815 · cited 1×
“In fact, IR and compensatory hyperinsulinemia may play a role in the pathogenesis of PCOS since insulin stimulates androgen production from theca cells [41] and decreases directly the production of steroid hormone binding protein (SHBG), leading to the increased levels of free, biologically active androgens, mainly te…”
BackgroundThe assessment of insulin resistance in man
Wallace, T. M., & Matthews, D. R. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00745.x · Cited by 677 · cited 1×
“Model Assessment of Insulin Resistance Index (HOMA IR Index1⁄4 {fasting glucose [mg/dl] fasting insulin [mU/ml]}/405) or other surrogates [30].”
MethodNestler, J. E., Jakubowicz, D. J., Falcon de Vargas, A., Brik, C., Quintero, N., & Medina, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4886 · Cited by 617 · cited 1×
“In fact, IR and compensatory hyperinsulinemia may play a role in the pathogenesis of PCOS since insulin stimulates androgen production from theca cells [41] and decreases directly the production of steroid hormone binding protein (SHBG), leading to the increased levels of free, biologically active androgens, mainly te…”
Background
Research works printed but not linked: 7
- Larner JD, 1999, Diabetes Rev, 7, 217
- Brusco GF1, 2013, Eur Rev Med Pharmacol Sci, 17, 3095
- Zhu X, 1994, Mol Pharmacol, 46, 460
- Larner J., 1994, Endocr J, 2, 167
- Rotterdam ESHRE/ASRMSponsored PCOS Consensus Workshop Group., 2004, Fertil Steril, 81, 19
- Nestler JE, 1998, J Clin Endocrinol Metab, 83, 2001
- Gerli S, 2007, Eur Rev Med Pharmacol Sci, 11, 347
Cited by
Inositols: From Established Knowledge to Novel Approaches
Dinicola, S., Unfer, V., Facchinetti, F., Soulage, C. O., Greene, N. D., Bizzarri, M., Laganà, A. S., Chan, S.-Y., Bevilacqua, A., Pkhaladze, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910575 · Cited by 154
“Based on this role, myoIns modulates the FSH-mediated anti-Mullerian hormone (AMH) production, playing a pivotal role in determining oocyte maturation and transport in the oviduct as well as ensuring the good quality of embryos [29].”
BackgroundInositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach
Laganà, A. S., Garzon, S., Casarin, J., Franchi, M., & Ghezzi, F. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.09.001 · Cited by 149
“The change of cAMP and increased calcium concentration promote the resumption of meiosis and release the mature oocyte [16].”
InfluentialGreff, D., Juhász, A. E., Váncsa, S., Váradi, A., Sipos, Z., Szinte, J., Park, S., Hegyi, P., Nyirády, P., Ács, N., et al. (2023) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-023-01055-z · Cited by 143
“Eligible studies used either myoinositol or D-chiro-inositol as the investigated intervention.”
BackgroundInfluentialCabrera-Cruz, H., Oróstica, L., Plaza-Parrochia, F., Torres-Pinto, I., Romero, C., & Vega, M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00162.2019 · Cited by 98
Facchinetti, F., Appetecchia, M., Aragona, C., Bevilacqua, A., Bezerra Espinola, M. S., Bizzarri, M., D’Anna, R., Dewailly, D., Diamanti-Kandarakis, E., Hernández Marín, I., et al. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1737675 · Cited by 63
Metadata
- Authors
- Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Department of Gynecological Endocrinology, Poznan University of Medical Science, Poznan, Poland and
- University of Modena and Reggio Emilia (IT)
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2016-09-01
- Volume
- 32
- Issue
- 9
- Pages
- 690-695
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2512910707
- Cited by
- 69
- References
- 63
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 22 · 2022: 5 · 2021: 15 · 2020: 7 · 2019: 6 · 2018: 2
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Keywords
- myo-inositol, D-chiro-inositol, inositol metabolism, insulin resistance, hypothyroidism, polycystic ovary syndrome, inositol supplementation, assisted reproduction, in vitro fertilization, follicular fluid, semen, phospholipids
- MeSH terms
- Female, Humans, Inositol, Insulin Resistance, Ovulation, Polycystic Ovary Syndrome, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inositol and human reproduction. From cellular metabolism to clinical use. https://app.cochat.ai/papers/10.1080/09513590.2016.1188282
- The paper
- Milewska, E. M., Czyzyk, A., Meczekalski, B., & Genazzani, A. D. (2016). Inositol and human reproduction. From cellular metabolism to clinical use. Gynecological Endocrinology. https://doi.org/10.1080/09513590.2016.1188282
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.